Avecon Healthcare Pvt. Ltd.

Avecon Healthcare Pvt. Ltd. specializes in in vitro diagnostic (IVD) test kits. Their portfolio includes automated hematology analyzers like the MAXCOUNT series (e.g., MAXCOUNT BH560, MAXCOUNT HMT 60P, MAXCOUNT HMT 70P) for analyzing blood cell counts, biochemistry analyzers such as the MAXLYTE and MAXLYZER SMART PLUS for measuring electrolytes and metabolic parameters, and systems like the AutoMax for automated sample processing. They also produce the MAXCLEAN, designed for reagent cleaning and maintenance.

Avecon Healthcare Pvt. Ltd. is based in India. Since their devices are marketed in the EU, they must comply with EU regulatory requirements for IVDs, including classification under EU MDR (Medical Device Regulation) and registration in EUDAMED, the European database for medical devices. The company’s devices fall under Class A classification in the EU, which typically involves lower regulatory scrutiny but still requires adherence to essential safety and performance standards.

Avecon Healthcare’s devices are listed in eudamed, the official EU database for medical devices. This registry is critical because it provides transparency on authorized devices within the European market, ensuring healthcare professionals and regulators can verify compliance with EU MDR requirements. Listing in eudamed confirms that the devices meet EU safety, performance, and traceability standards.

Avecon Healthcare’s devices are classified under Class A in the EU. This classification applies to low-risk IVDs, such as certain diagnostic test kits and analyzers. While Class A devices generally face less stringent regulatory oversight compared to higher-risk classes, they still must comply with EU MDR requirements, including risk management, labeling, and post-market surveillance. The classification ensures that even low-risk devices meet fundamental safety and performance criteria.